TickerTain — Make Analysis Fun Again

▶ 28:20 · $GOOGL · Las farmacéuticas pagan decenas de millones por esta IA | Biorce

episode shorts · 1

Gestionar ensayos clínicos

now playing · $GOOGL

DeepMind partnership enables Biorce's reasoning model training approach

Biorce has a strategic partnership with Google/DeepMind where the Head of Research shared pre-public reasoning training techniques (Chain of Thought) that Biorce adopted to train…

$ANTHROPICneutral· mediumpedro coelho

Biorce uses Anthropic as best-in-class for math/statistics tasks in model orchestration

Biorce's model orchestrator routes tasks to the best model: proprietary models for domain-specific clinical reasoning, Anthropic for mathematics/statistics/SQL where frontier mode…

$FORMATION-BIOneutral· mediumpedro coelho

Formation Bio raises billions to become AI-native pharma, not infrastructure

Formation Bio took the opposite approach to Biorce: raising billions to develop drugs themselves as an AI-native pharmaceutical company rather than selling infrastructure to pharm…

$BIORCEbullish· high· pospedro coelho

Biorce reaches $10M ARR in 9 months, targets $10B+ revenue clinical trial OS

Biorce's AI operating system for clinical trials cuts protocol creation from 18 months to 10 minutes with 95% accuracy, reducing pharma R&D costs by 50-70%. The company achieved ~…

$MAZEbullish· mediumpedro coelho

Maze Impact first institutional investor in Biorce, backed pre-seed at 3.5M EUR

Maze (Portuguese impact fund) was the first investor to understand Biorce's hybrid tech-bio positioning, committing 1M EUR in pre-seed when health tech and pure tech funds both pa…

$NORSKENbullish· highpedro coelho

Norsken converts CL to equity at 9x ARR multiple after witnessing pharma demand

Norsken invested via a convertible note with revenue-based conversion (9-10x ARR) after observing Biorce's team execution and a major pharma visit where 7 leadership members reque…

$DST-GLOBALbullish· highpedro coelho

DST Global leads Biorce Series A after 3-day founder shadowing, no reference calls

DST Global (Yuri Milner) invested in Biorce's $52.5M Series A after intensive due diligence including 3-day founder shadowing and a demo to ex-GSK/Genentech/Rush executives. They…

$BAYRY···neutral· highpedro coelho

Bayer offers ~$2B for Biorce, turned down to remain neutral infrastructure

A major pharma (likely Bayer per context) offered approximately $2B cash for Biorce. The founder rejected it because selling to one pharma would compromise the neutral infrastruct…

←